Structure Therapeutics (GPCR) Current Assets (2022 - 2026)

Quarterly Current Assets rose 75.44% to $1.5 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.5 billion through Mar 2026, up 75.44% year-over-year, with the annual reading at $1.6 billion for FY2025, 76.2% up from the prior year.

Structure Therapeutics' Current Assets history spans 5 years, with the latest figure at $1.5 billion for Q1 2026.

  • Current Assets came in at $1.5 billion for Q1 2026, down from $1.6 billion in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $1.6 billion in Q4 2025 to a low of $93.1 million in Q4 2022.
  • The 5-year median for Current Assets is $806.7 million (2025), against an average of $712.6 million.
  • Year-over-year, Current Assets soared 408.77% in 2023 and then dropped 14.75% in 2025.
  • Structure Therapeutics' Current Assets stood at $93.1 million in 2022, then skyrocketed by 408.77% to $473.6 million in 2023, then skyrocketed by 88.17% to $891.2 million in 2024, then skyrocketed by 76.2% to $1.6 billion in 2025, then fell by 5.08% to $1.5 billion in 2026.
  • Per Business Quant, the three most recent readings for GPCR's Current Assets are $1.5 billion (Q1 2026), $1.6 billion (Q4 2025), and $814.0 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - 10.37 Mn
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - 37.31 Mn
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn 1.25 Bn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - 73.04 Mn
5 Akari Therapeutics 605.66 Bn 605.66 Bn - 3.59 Mn
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 11.73 Bn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 18.21 Bn
8 Evaxion A 65.12 Bn 65.10 Bn - -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 4.22 Bn
10 Structure Therapeutics 8.43 Bn 8.43 Bn - 1.49 Bn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1.49 Bn
Dec 31, 2025 1.57 Bn
Sep 30, 2025 814.02 Mn
Jun 30, 2025 799.30 Mn
Mar 31, 2025 849.62 Mn
Dec 31, 2024 891.21 Mn
Sep 30, 2024 923.65 Mn
Jun 30, 2024 937.62 Mn
Mar 31, 2024 449.36 Mn
Dec 31, 2023 473.61 Mn
Sep 30, 2023 209.96 Mn
Jun 30, 2023 228.22 Mn
Mar 31, 2023 246.16 Mn
Dec 31, 2022 93.09 Mn